Kuang‐Hung Cheng

5.2k citations

58 papers · 4.1k indexed · 2 hit papers · h-index 26

Molecular Biology top 2%
Oncology top 2%
Cancer Research top 2%
Genetics top 5%
Surgery top 10%

Co-authors: Sam Thiagalingam Jose F. Ponte Arunthathi Thiagalingam Hyunjoo Jean Lee Nora D. Mineva Ronald A. DePinho Nabeel Bardeesy Gerald C. Chu
Topics: Pancreatic and Hepatic Oncology Research (13 papers)Epigenetics and DNA Methylation (10 papers)Cancer Cells and Metastasis (9 papers)
Cited by: Oncology Cancer Research Biological Psychiatry
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation Genes & Development
Partner nations: Taiwan United States United Kingdom

In The Last Decade

Kuang‐Hung Cheng

58 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code

2003 555 citations Sam Thiagalingam, Kuang‐Hung Cheng et al. Annals of the New York Academy of Sciences profile →
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

2006 506 citations Nabeel Bardeesy, Kuang‐Hung Cheng et al. Genes & Development profile →

Peers

Countries citing papers authored by Kuang‐Hung Cheng

Since Specialization

Citations

This map shows the geographic impact of Kuang‐Hung Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuang‐Hung Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuang‐Hung Cheng more than expected).

Fields of papers citing papers by Kuang‐Hung Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuang‐Hung Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuang‐Hung Cheng. The network helps show where Kuang‐Hung Cheng may publish in the future.

Co-authorship network of co-authors of Kuang‐Hung Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Kuang‐Hung Cheng. A scholar is included among the top collaborators of Kuang‐Hung Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuang‐Hung Cheng. Kuang‐Hung Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Haploinsufficiency of Adenomatous Polyposis Coli Coupled with Kirsten Rat Sarcoma Viral Oncogene Homologue Activation and P53 Loss Provokes High-Grade Glioblastoma Formation in Mice 2024 ·Cancers ·(unknown),(unknown),(unknown),(unknown),Kuang‐Hung Cheng	1
2	IL17RB expression is associated with malignant cancer behaviors and poor prognosis in oral cancer 2023 ·Oral Diseases ·Shyng‐Shiou F. Yuan,Changwei Su,Leong‐Perng Chan,(unknown),Yuk‐Kwan Chen,Je‐Kang Du,Kuang‐Hung Cheng,Yen‐Yun Wang	2
3	Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis 2023 ·International Journal of Oncology ·Yen‐Yun Wang,Kuang‐Hung Cheng,Amos C. Hung,Steven Lo,(unknown),Yi‐Chia Wu,Ming‐Feng Hou,Shyng‐Shiou F. Yuan	2
4	CD44 Promotes Lung Cancer Cell Metastasis through ERK–ZEB1 Signaling 2021 ·Cancers ·Yen‐Yun Wang,(unknown),Ping‐Ho Chen,(unknown),Chih-Yeh Chao,Kuang‐Hung Cheng,(unknown),Stephen Chu‐Sung Hu,Shyng‐Shiou F. Yuan	27
5	KRAS K104 modification affects the KRASG12D-GEF interaction and mediates cell growth and motility 2020 ·Scientific Reports ·Chih-Chieh Chen,Chia‐Yi Hsu,Hsiao‐Yun Lin,(unknown),Kuang‐Hung Cheng,Chia‐Wei Wu,Eing‐Mei Tsai,Tsung‐Hua Hsieh	2
6	MAL‐PDT inhibits oral precancerous cells and lesions via autophagic cell death 2019 ·Oral Diseases ·Yen‐Yun Wang,Yuk‐Kwan Chen,Stephen Chu‐Sung Hu,(unknown),(unknown),(unknown),Kuang‐Hung Cheng,Yun‐Ming Wang,Shyng‐Shiou F. Yuan	16
7	β-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer 2018 ·Theranostics ·Tzu‐Lei Kuo,Kuang‐Hung Cheng,Yan‐Shen Shan,Li‐Tzong Chen,Wen-Chun Hung	29
8	Pancreatic Tumor Progression Associated With CD133 Overexpression 2015 ·Pancreas ·(unknown),Kung‐Kai Kuo,(unknown),Pi‐Jung Hsiao,Yu‐Wen Chen,Deng-Chyang Wu,Wen‐Chun Hung,Kuang‐Hung Cheng	23
9	Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma 2015 ·Pancreas ·Kung‐Kai Kuo,(unknown),(unknown),Shih‐Shin Liang,Chun‐Hao Huang,(unknown),Kun‐Bow Tsai,Chiao‐Yun Chen,Edward Hsi,Kuang‐Hung Cheng,Shyh‐Horng Chiou	16
10	Utilization of Liquid Chromatography Mass Spectrometry Analyses to Identify LKB1–APC Interaction in Modulating Wnt/β-Catenin Pathway of Lung Cancer Cells 2014 ·Molecular Cancer Research ·Shu‐Fang Jian,Chang‐Chun Hsiao,Shin‐Yi Chen,(unknown),Tzu‐Lei Kuo,Deng-Chyang Wu,Wen‐Chun Hung,Kuang‐Hung Cheng	11
11	17β-Estradiol inhibition of IL-6–Src and Cas and paxillin pathway suppresses human mesenchymal stem cells–mediated gastric cancer cell motility 2014 ·Translational research ·Chung‐Jung Liu,Fu‐Chen Kuo,Huang‐Ming Hu,Chiao‐Yun Chen,Yaw‐Bin Huang,Kuang‐Hung Cheng,Kazunari K. Yokoyama,Deng‐Chyang Wu,Shuchen Hsieh,Chao‐Hung Kuo	17
12	SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells 2014 ·BMC Cancer ·Yuwen Chen,Pi‐Jung Hsiao,(unknown),Kung‐Kai Kuo,Tzu‐Lei Kuo,Deng‐Chyang Wu,Wen‐Chun Hung,Kuang‐Hung Cheng	54
13	Stem Cell Marker Nestin Is Critical for TGF-β1-Mediated Tumor Progression in Pancreatic Cancer 2013 ·Molecular Cancer Research ·(unknown),(unknown),Pi‐Jung Hsiao,Lihua Chen,Tzu‐Lei Kuo,Yu‐Wen Chen,Kung‐Kai Kuo,Kuang‐Hung Cheng	70
14	RECK Inhibits Stemness Gene Expression and Tumorigenicity of Gastric Cancer Cells by Suppressing ADAM‐Mediated Notch1 Activation 2013 ·Journal of Cellular Physiology ·(unknown),Deng‐Chyang Wu,Kuang‐Hung Cheng,Li‐Tzong Chen,Wen‐Chun Hung	56
15	The Activation of MEK/ERK Signaling Pathway by Bone Morphogenetic Protein 4 to Increase Hepatocellular Carcinoma Cell Proliferation and Migration 2012 ·Molecular Cancer Research ·(unknown),Kung‐Kai Kuo,Tzu‐Lei Kuo,(unknown),Kuang‐Hung Cheng	61
16	Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer 2011 ·Cancer Research ·Panagiotis Papageorgis,Kuang‐Hung Cheng,Sait Öztürk,Yi Gong,Arthur W. Lambert,Hamid M. Abdolmaleky,Jin‐Rong Zhou,Sam Thiagalingam	172
17	Human adipose-derived stem cells: Isolation, characterization and current application in regeneration medicine 2011 ·Kuang‐Hung Cheng,Tzu‐Lei Kuo,Kung‐Kai Kuo,Chang‐Chun Hsiao	44
18	Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder 2006 ·Human Molecular Genetics ·Hamid M. Abdolmaleky,Kuang‐Hung Cheng,Stephen V. Faraone,Marsha Wilcox,Stephen J. Glatt,(unknown),Cassandra L. Smith,Rahim Shafa,(unknown),(unknown),Hongjie Pan,Panagiotis Papageorgis,Jose F. Ponte,V. Sivaraman,Ming T. Tsuang,Sam Thiagalingam	346
19	Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancerbreakdown → 2006 ·Genes & Development ·Nabeel Bardeesy,Kuang‐Hung Cheng,Justin H. Berger,Gerald C. Chu,Jessica Pahler,Peter Olson,Aram F. Hezel,James W. Horner,Gregory Y. Lauwers,Douglas Hanahan,Ronald A. DePinho	506
20	Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Codebreakdown → 2003 ·Annals of the New York Academy of Sciences ·Sam Thiagalingam,Kuang‐Hung Cheng,Hyunjoo Jean Lee,Nora D. Mineva,Arunthathi Thiagalingam,Jose F. Ponte	555

About Kuang‐Hung Cheng

Kuang‐Hung Cheng is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 58 papers that have together received 4.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Epigenetics and DNA Methylation (10 papers) and Cancer Cells and Metastasis (9 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (794 citations) and Biological Psychiatry (99 citations). Kuang‐Hung Cheng has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Sam Thiagalingam, Jose F. Ponte, Arunthathi Thiagalingam, Hyunjoo Jean Lee, Nora D. Mineva, Ronald A. DePinho, Nabeel Bardeesy, Gerald C. Chu, Aram F. Hezel and Douglas Hanahan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact